GDP temperature monitoring requirements are often reduced to one question: did the medicine stay within range? When teams evaluate a GDP temperature monitoring system or ask for GDP-compliant temperature monitoring, the practical question is broader. It is about preserving the quality and integrity of medicinal products while they are stored, handled, transported, received, returned, quarantined and reviewed.
For temperature monitoring, that means teams need more than a thermometer reading or a downloaded logger file. They need a record that shows what was monitored, which limits applied, whether a temperature excursion occurred, who was alerted, who acknowledged the event, and what evidence is available for later quality review.
KRYOS fits this workflow as the environmental evidence layer for a GDP-oriented temperature monitoring system. It supports continuous temperature monitoring, configured thresholds, temperature alerts, acknowledgements, response notes, reports and exports. It can support GDP-oriented monitoring, but it does not make an organisation GDP compliant by itself. Product disposition, deviation handling, CAPA, SOPs, staff training, supplier qualification and final quality sign-off remain with the customer’s quality system.
If you are comparing requirements with an operational system, use this article as the background guide, then review the KRYOS GDP temperature monitoring page for the monitoring workflow. If you need to map rooms, transport points, alert owners and report evidence against your SOPs, request a demo with that scope.
What GDP means for temperature monitoring
Good Distribution Practice sets expectations for the distribution of medicinal products. In the EU context, GDP is used to help ensure that medicines are authorised, stored in the right conditions, protected from contamination, managed with appropriate stock turnover and delivered to the correct recipient in an acceptable timeframe. The European Medicines Agency GDP overview frames GDP around maintaining medicine quality throughout distribution.
For monitoring teams, the practical point is simple: medicines should be stored and transported under suitable conditions according to the product’s requirements. Those requirements may come from product labelling, manufacturer guidance, stability information, quality agreements, SOPs, or local regulatory expectations.
That is why GDP temperature monitoring requirements are not identical for every product or workflow. One product may require refrigerated storage. Another may require controlled ambient storage. Another may be especially sensitive to freezing. A warehouse zone, vehicle route, return area or receiving hold can each create a different quality question.
A useful GDP monitoring setup should answer five evidence questions without taking over the decisions that belong in the quality system:
| GDP monitoring question | Evidence the monitoring layer should retain | Decision that remains with the quality system |
|---|---|---|
| What condition and scope applied? | Product or storage context, monitored site or asset, route or handoff where configured, and the applicable upper and lower limits. | Define the required conditions, scope and acceptance criteria. |
| Was monitoring continuous and usable? | Time-stamped readings, missing-data periods, device state, sensor or probe identity and assignment history. | Decide whether a gap is acceptable and what follow-up is required. |
| What happened during an excursion? | Threshold, start and end, duration, minimum or maximum exposure, alert delivery, acknowledgement and response notes. | Classify the deviation, assess product impact, decide CAPA and determine disposition. |
| Can the measurement be trusted? | Calibration or certificate context, device health, probe placement and replacement history where configured. | Approve qualification, mapping, calibration policy and validation. |
| Can the record be reviewed later? | Site and asset identity, local-time context, report period, exportable readings, alert history and audit trail. | Set retention, approve the review and provide final quality sign-off. |
GDP temperature monitoring is not only 2 to 8 degrees Celsius
Many refrigerated medicines are stored around 2 to 8 degrees Celsius, so that range appears frequently in GDP temperature monitoring conversations. It should still be treated as a common example, not a universal rule.
GDP-oriented monitoring can involve:
- controlled ambient rooms
- refrigerated cold rooms
- medicine refrigerators
- freezer rooms where relevant
- do-not-freeze products
- dispatch preparation and temporary holds
- loading bays
- transport vehicles
- monitored containers or boxes when configured
- receiving areas
- returns areas
- quarantine areas
- temporary holds
- humidity-sensitive areas where relevant.
The correct limits should be defined by the customer’s quality process. KRYOS can help apply configured limits, detect events, route alerts and preserve records. It does not decide the required storage condition for a medicinal product.
Storage requirements: rooms, zones and temporary holds
GDP monitoring often starts with storage, but storage is rarely just one cold room.
A pharmaceutical distributor, wholesaler, logistics provider or outsourced storage operation may have goods-in areas, controlled ambient rooms, refrigerated rooms, freezer rooms, picking zones, packing areas, dispatch holds, returns, quarantine, rejected deliveries awaiting review and temporary QA holds.
Each point can create a temperature record that may matter later. A product may remain stable in the main cold room but face exposure during receiving, picking, dispatch preparation or return review. If those points are not monitored, quality teams may have to reconstruct the temperature story after the fact.
A practical GDP temperature monitoring setup should map the storage workflow and decide which points need continuous monitoring, which can rely on documented checks, and which are controlled through SOPs or other procedures.
KRYOS can support storage monitoring by keeping readings, thresholds, alerts, response notes and exports tied to the relevant site, room, asset, zone or storage point where configured.
Transport requirements: dispatch to receiving
GDP temperature monitoring also applies during transport. The European Commission Guidelines on Good Distribution Practice of medicinal products for human use include transport expectations, including that required storage conditions should be maintained during transportation and that customers should be provided with data demonstrating conditions during transport if requested.
In practical terms, a transport record may need to explain:
- pre-dispatch storage conditions
- packing or dispatch preparation exposure
- loading delay
- vehicle, container or box monitoring where configured
- route or lane context when configured
- carrier, courier or receiving transfer point
- route delay
- receiving delay
- temporary QA hold
- whether the shipment needs quarantine, deviation review or product disposition.
A passive data logger may provide a temperature file after delivery. That can be useful. Active GDP temperature monitoring becomes more useful when the team needs to know about an issue while the route is still active.
KRYOS can help where transport monitoring is configured by connecting route or monitored transport-point readings with alerts, acknowledgements, response notes and exports. It should not be described as a transport management system, inventory system or chain-of-custody platform unless those functions are explicitly supported in the implementation.
Alerts and excursions: when the record becomes evidence
GDP temperature monitoring requirements are not satisfied by collecting numbers alone. When a temperature excursion occurs, the record becomes part of a quality review.
A useful excursion record should include:
- the monitored point
- configured threshold
- event start and end
- duration
- minimum and maximum exposure
- too-warm or too-cold context
- alarm state
- responsible owner or team
- acknowledgement
- escalation context
- response notes
- recovery context
- report or export.
This is where many workflows break down. Temperature traces, emails, phone notes, screenshots, logger files and deviation records can end up in separate places. Later, a quality team may need to rebuild the event manually.
KRYOS supports GDP-oriented excursion review by keeping the monitoring record, alert context, acknowledgement, response notes and exportable evidence closer together.
The boundary matters. KRYOS provides environmental evidence. The customer’s quality system decides how the excursion is classified, whether a deviation is opened, whether CAPA is required and what happens to the product.
Returns and quarantine need condition history too
GDP monitoring does not end after dispatch or delivery. Returns, rejected deliveries and quarantine areas can create their own temperature questions.
Common examples include:
- a customer returns product after uncertain handling
- a delivery is rejected and placed on hold
- a shipment arrives after a temperature alarm
- returned stock waits for QA review
- product is quarantined pending manufacturer advice
- stock awaits disposal or return-to-stock decision.
The temperature history during this review period can matter. A product may already be questionable, but it still needs to be stored under suitable conditions until the business decides what happens next.
KRYOS can help monitor returns, quarantine and temporary hold areas where configured. It can preserve readings, incidents and reports, but it does not decide acceptance, rejection, disposal or return to stock.
Calibration, sensors and measurement context
GDP-oriented reviewers may ask whether the measurement record is reliable. That makes sensor identity, probe placement, device health and calibration context important.
A good monitoring setup should consider:
- which sensor or probe measured the condition
- where the probe was placed
- whether the device was suitable for the monitored point
- whether calibration or certificate context is available
- whether device health and battery state are visible
- how recalibration or replacement is handled
- whether records remain linked to the monitored asset.
Temperature mapping may also be relevant for storage areas. The WHO technical supplement on temperature mapping of storage areas describes a documented study used to identify temperature distribution, including hot and cold spots. Mapping and qualification help determine whether a space is suitable and where routine sensors should be placed; continuous monitoring then preserves day-to-day evidence after the space is in use.
KRYOS supports that ongoing monitoring layer by keeping sensor identities, probe placement, readings, alerts, response notes, reports and audit logs connected to the monitored point. It does not replace the customer’s mapping protocol, qualification decision or validation report. The related sensors and probes, installation and validation and reports and audit logs pages explain this boundary in more detail.
Reports and exports: what GDP review needs later
GDP temperature monitoring records should be retrievable. A record that exists but cannot be found quickly is not useful during a quality review, customer question, self-inspection or audit.
Reports and exports may need to show:
- date range
- monitored site, room, route, shipment, asset or zone
- temperature and humidity history where relevant
- threshold configuration
- alarms and incident timeline
- event duration
- min/max exposure
- acknowledgement
- response notes
- sensor or probe context
- export history when configured.
This is the difference between a raw temperature log and a review-ready monitoring record. A raw log shows values. A review-ready record explains the event.
KRYOS helps teams export records for GDP-oriented review without rebuilding evidence from paper logs, data logger files, emails, screenshots and separate notes. The related cold-chain temperature logs and audit-ready temperature records pages explain this documentation layer in more detail.
What KRYOS supports in a GDP-oriented workflow
KRYOS can support pharmaceutical temperature monitoring compliance workflows by connecting:
- continuous temperature history
- humidity history where relevant
- configured thresholds
- high and low alerts
- disconnection notifications where configured
- alert owners
- acknowledgements
- response notes
- incident timelines
- duration and min/max exposure
- sensor and probe context
- reports and exports
- storage, transport, return or quarantine context when configured.
This makes KRYOS relevant for wholesalers, distributors, pharmaceutical logistics teams, outsourced storage providers, quality teams, Responsible Person workflows, warehouse teams and transport operations.
It is still not the GDP quality system. KRYOS does not replace SOPs, staff training, supplier qualification, deviation handling, CAPA, product disposition, route qualification, validation or final sign-off.
A safe way to think about the boundary is:
KRYOS preserves the environmental evidence. Your quality system keeps the GDP decision.
GDP temperature monitoring checklist
A practical GDP temperature monitoring process should define:
- which products and storage conditions apply
- which rooms, assets, vehicles, routes or storage points need monitoring
- upper and lower alarm limits
- humidity limits where relevant
- alert delays and escalation paths
- responsible owners
- response-note expectations
- calibration and sensor documentation
- transport and responsibility-transfer record needs
- returns and quarantine monitoring
- report and export requirements
- retention requirements for monitoring records
- how excursions are reviewed inside the quality system.
This checklist should be adapted to the product, operation, country, SOPs and quality requirements.
Primary guidance used for this overview
This article interprets monitoring and evidence implications rather than replacing legal, regulatory or quality-system review. The primary references used are:
- the European Medicines Agency overview of Good Distribution Practice
- the European Commission Guidelines on Good Distribution Practice of medicinal products for human use
- the WHO technical supplement on temperature and humidity monitoring systems for fixed storage areas.
Conclusion: GDP monitoring is about evidence continuity
GDP temperature monitoring requirements are not only about collecting temperature readings. They are about maintaining suitable conditions and preserving the evidence needed to explain what happened across storage, transport, responsibility transfers, returns, quarantine and review.
The strongest monitoring workflows keep the record connected: monitored point, required condition, threshold, alert, owner, response, exposure, report and quality review.
If your team needs a GDP-oriented temperature monitoring system with active alerts, incident context and exportable records, review KRYOS GDP temperature monitoring.
Need GDP-oriented temperature records?
See how KRYOS preserves monitoring evidence for controlled storage, transport context, deviations, responsibilities, and review.
